• News (37)
    City AM (21 Aug 2019)

    Bayer to sell animal health business to Elanco in $7.6bn deal

    BAYER is to sell its animal health business to US firm Elanco for $7.6bn (£6.3bn), to help raise money, as the company continues to offload assets in the face of its Roundup weed killer lawsuit. The deal is subject to regulatory approval but will make it the second largest veterinary medicine business in the world, behind industry leader Zoetis. Bayer will receive $5.3bn in cash alongside $2.3bn of Elanco stock. It is expected the transaction will be completed by mid-2020.

    Read Full Article

    PR Week (05 Feb 2019)

    Bayer appoints WA Health

    BAYER has handed its government affairs for its cardiovascular treatment to WA Health following a competitive pitch. The agency is tasked with supporting Bayer’s market-access work to assist its expansion into coronary or peripheral arterial disease, as well as its work in anti-coagulation for stroke prevention. The agency team will report to Andrew Brown, Bayer's government and industry affairs manager.

    Read Full Article